Laboratory and pharmacologic studies of BL-P-1322 (cephapirin sodium) in children.
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D002511:Cephalosporins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002512:Cephalothin / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D004802:Eosinophilia / Q000139:chemically induced; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008826:Microbial Sensitivity Tests; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use
D000081:Acetamides; D002511:Cephalosporins; D011725:Pyridines; D002512:Cephalothin